The UK Anti Doping Agency (UKAD) have confirmed they've been lobbying the World Anti Doping Agency (WADA) for three years to introduce a blanket ban of the drug used by Bradley Wiggins – triamcinolone acetonide – and other such glucocorticoids.
They have also pushed for a ban on tramadol, the powerful painkiller that riders have claimed has been used both at British Cycling and at Team Sky.
Glucocorticoids are banned in competition under WADA rules, though athletes can take them if they avail of a Therapeutic Use Exemption (TUE), as Wiggins did with triamcinolone ahead of the 2011 and 2012 Tours de France and the 2013 Giro d'Italia. They are not, however, banned outside of competition.
UKAD confirmed to Cyclingnews on Thursday that for the last three years they have called for a complete blanket ban on glucocorticoids as part of WADA's annual consultation process that precedes the publication of its banned list.
Some former dopers have attested to the performance enhancing qualities of triamcinolone, and UKAD cite glucocorticoids' weight loss properties – with power to weight ratio a crucial tenet of cycling performance – in calling for an out-of-competition ban.
"UKAD has raised concerns in its submissions for the last three years about the potential misuse of glucocorticoids out-of-competition, primarily to assist with weight loss," read a statement sent to Cyclingnews on Thursday.
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2edZpr4
No comments:
Post a Comment